Device Trial Radar · NCT00636987
Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra
Last checked: Nov 20, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
297
Actual
Start
Apr 2007
Primary completion
Oct 2015
Study completion Mar 2016
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Mar 17, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to further evaluate the long-term safety and effectiveness of the Biocor and Biocor Supra Valves.
Conditions
- Aortic Valve Insufficiency
- Aortic Valve Regurgitation
- Aortic Valve Stenosis
- Aortic Valve Incompetence
- Mitral Valve Insufficiency
- Mitral Valve Regurgitation
- Mitral Valve Stenosis
- Mitral Valve Incompetence
Interventions
Biocor and Biocor Supra valvesDevice
Replacement for a diseased, damaged, malformed aortic or mitral heart valve
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse EventsTime frame: 5 Years
- Characterize Patient NYHA Functional Classification StatusTime frame: 5 year
- Characterize the Hemodynamic Performance of the ValveTime frame: 5 Year
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Scripps Green Hospital/Scripps Clinic
La Jolla, California
USC University Hospital, Department of Cardiothoracic Surgery
Los Angeles, California
The Heart Group, PC
Evansville, Indiana
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.